Mahilum, Federico .

HRN: 17-25-09  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2025
CEFTRIAXONE 1G (VIAL)
01/17/2025
01/24/2025
IVTT
1 Gm
Q 12h
Stab Wound
Waiting Final Action 
01/25/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/25/2025
02/01/2025
IVT
4.5 Gm
Q 8h
Stab Wound
Waiting Final Action 
01/26/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/26/2025
02/02/2025
IV
4.5g
Q6
Stab Wound
Waiting Final Action 
01/26/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
01/26/2025
02/01/2025
IV
750mg
OD
SEPSIS
Waiting Final Action 
01/30/2025
MUPIROCIN 2%, 15G (TUBE)
01/30/2025
02/06/2025
TOPICAL
Apply Thinly
Bid
Irritant Dermatitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: